Genomic insights and evaluation of Bacillus spizizenii Endophyte from Solanum elaeagnifolium Cav against multidrug-resistant pathogens
Endophytic bacterium Bacillus spizizenii from Solanum elaeagnifolium represents a promising resource for developing new antimicrobial and antiviral therapeutics, and its extracts showed both qualitative and quantitative inhibitory activity against a broad range of standard and multidrug-resistant pathogens.